| α-KGDDs | Alpha-ketoglutarate- and Fe2+-dependent dioxygenases |
| ARCH | Age-related clonal hematopoiesis |
| Arg1 | Arginase 1 |
| AML | Acute myeloid leukemia |
| CCUS | Clonal cytopenia of undetermined significance |
| CH | Clonal hematopoiesis |
| CHIP | Clonal hematopoiesis of indeterminant potential |
| CMML | Chronic myelomonocytic leukemia |
| COPD | Chronic obstructive pulmonary disease |
| DNMT3A | DNA methyltransferase 3 alpha |
| DOT1L | Disruptor of telomeric silencing 1-like |
| GERD | Gastro-esophageal reflux disease |
| HDAC2 | Histone deacetylase 2 |
| HMA | Hypomethylating agents |
| HSC | Hematopoietic stem cells |
| HSPC | Hematopoietic stem/progenitor cells |
| ICUS | Idiopathic cytopenia of undetermined significance |
| IL-1β | Interleukin 1 beta |
| IL-18 | Interleukin 18 |
| IL-6 | Interleukin 6 |
| IL6R | Interleukin 6 receptor |
| LPS | Lipopolysaccharides |
| MDS | Myelodysplastic syndromes |
| MDS-RS | MDS with ring sideroblasts |
| MDS/MPN | Myelodysplastic syndromes/myeloproliferative neoplasms |
| MPN | Myeloproliferative neoplasm |
| NGS | Next-generation sequencing |
| NLRP3 | Nod-like receptor family pyrin domain containing 3 |
| RARS | Refractory anemia with ring sideroblasts |
| SAM | S-adenosyl-l-methionine |
| TET2 | Tet methylcytosine dioxygenase 2 |
| TNF-α | Tumour necrosis factor alpha |
| VAF | Variant allele frequency |
| 5mC | 5-methylcytosine |
| 5hmC | 5-hydroxymethylcytosine |